GG 18 (Perphenazine 2 mg)
Pill imprint GG 18 has been identified as Perphenazine 2 mg.
Perphenazine is used in the treatment of psychosis; bipolar disorder; nausea/vomiting and belongs to the drug classes phenothiazine antiemetics, phenothiazine antipsychotics. FDA has not classified the drug for risk during pregnancy. Perphenazine 2 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- GG 18
- Strength:
- 2 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Phenothiazine antiemetics
Phenothiazine antipsychotics - Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-1046
- Inactive Ingredients:
- microcrystalline cellulose
hydroxypropyl cellulose
hypromelloses
hypromellose 2910 (3 mPa.s)
lactose monohydrate
magnesium stearate
polyethylene glycol
polysorbate 80
corn starch
titanium dioxide
More about perphenazine
Consumer resources
- Other brands: Trilafon
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
